SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-026006
Filing Date
2020-12-29
Accepted
2020-12-29 07:29:51
Documents
16
Period of Report
2020-12-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20201228_8k.htm   iXBRL 8-K 28005
2 EXHIBIT 99.1 ex_219166.htm EX-99.1 10876
7 ex_219166img001.jpg GRAPHIC 4564
8 mbrx20201228_8kimg001.jpg GRAPHIC 3620
  Complete submission text file 0001437749-20-026006.txt   196548

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20201229.xsd EX-101.SCH 3702
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20201229_def.xml EX-101.DEF 11974
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20201229_lab.xml EX-101.LAB 16012
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20201229_pre.xml EX-101.PRE 12183
9 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20201228_8k_htm.xml XML 2656
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 201420268
SIC: 2834 Pharmaceutical Preparations